$30 million man: Clayton Kershaw and the Dodgers reportedly agree to a seven-year, $215 million deal

72 Comments

People were throwing around numbers like $300 million, and this isn’t that. But it’s pretty incredible all the same: ESPN is reporting that the Dodgers and Clayton Kershaw have agreed on a seven year, $215 million contract, with an opt-out after five years. That breaks down to an average annual value of over $30 million a year.

There are good things for both sides here. The five-year opt-out provision gives Kershaw a chance to make even more than this if, come five years from now, he’s even better or still elite and the top dollars for pitchers have gone up.  Put differently: the guy who just signed a gigantic deal at age 25 can do it again at age 30 is he wants to. The amount of money this young man stands to make in the next 10-12 years is mind-boggling.

And even if the the opt-out provision is not exercised, the Dodgers are only on the hook for Kershaw through his age-32 season, which does not present nearly the sort of risk that many mega-deals do, as they often take players through their late 30s or into their 40s.

Kershaw has won two of the past three NL Cy Young Awards and was the runner up the third time. He’s 77-46 in his career with a 2.60 ERA in 184 career games.  In the past three seasons he is 51-23 with an ERA of 2.21.

He’s quite simply the best pitcher in the game. And he is now the highest paid player — on an average annual salary basis — in all of baseball.

Marcus Stroman dealing with blister again

Marcus Stroman
Getty Images
Leave a comment

Blue Jays right-hander Marcus Stroman might be headed to the disabled list soon, manager John Gibbons told reporters following Friday’s rain-shortened loss to the Yankees. The righty lasted just four innings on the mound before calling it a night, and gave up five runs, six hits and two walks in a performance that Gibbons claimed was at least partially affected by recurring blister issues on his right middle finger. Now, it looks like he might be removed from the rotation for some much-needed rest and rehabilitation; if so, it’ll be his second such stint this year.

Stroman, 27, has struggled to return the kind of winning record and sub-4.00 ERA that characterized his previous seasons with the club, mostly due to the combined seven weeks he missed with blisters on his throwing hand and chronic fatigue in his right shoulder. In a recent start against the Rays, things got even more gruesome when his blister appeared to start bleeding in the middle of his outing and MLB.com’s Gregor Chisholm notes that the wound has constantly interfered with the right-hander’s pitch selection and delivery. When healthy, Stroman has managed a 4-8 record through 18 starts in 2018 with a career-worst 5.27 ERA, 3.2 BB/9 and 6.8 SO/9 in 100 2/3 innings. This will be the first year since 2015 in which he has not logged at least 200 innings in a single season.

While Stroman may not need an extended stay on the DL before he returns to the mound, it’s not clear what kind of timetable the Blue Jays expect for his recovery. He’s been the second-most valuable starter (behind the now-traded J.A. Happ) in a rotation that currently ranks 17th in the majors with a combined 4.90 ERA and 6.8 fWAR.